|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abdollah F, Gandaglia G, Thuret R,
Schmitges J, Tian Z, Jeldres C, Passoni NM, Briganti A, Shariat SF,
Perrotte P, et al: Incidence, survival and mortality rates of
stage-specific bladder cancer in United States: A trend analysis.
Cancer Epidemiol. 37:219–225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cancer Genome Atlas Research Network:
Comprehensive molecular characterization of urothelial bladder
carcinoma. Nature. 507:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matta A, Siu KW and Ralhan R: 14-3-3 zeta
as novel molecular target for cancer therapy. Expert Opin Ther
Targets. 16:515–523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aghazadeh Y and Papadopoulos V: The role
of the 14-3-3 protein family in health, disease, and drug
development. Drug Discov Today. 21:278–287. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Neal CL, Yao J, Yang W, Zhou X, Nguyen NT,
Lu J, Danes CG, Guo H, Lan KH, Ensor J, et al: 14-3-3zeta
overexpression defines high risk for breast cancer recurrence and
promotes cancer cell survival. Cancer Res. 69:3425–3432. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Murata T, Takayama K, Urano T, Fujimura T,
Ashikari D, Obinata D, Horie-Inoue K, Takahashi S, Ouchi Y, Homma
Y, et al: 14-3-3ζ, a novel androgen-responsive gene, is upregulated
in prostate cancer and promotes prostate cancer cell proliferation
and survival. Clin Cancer Res. 18:5617–5627. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao GY, Ding JY, Lu CL, Lin ZW and Guo J:
The overexpression of 14-3-3ζ and Hsp27 promotes non-small cell
lung cancer progression. Cancer. 120:652–663. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jin LM, Han XH, Jie YQ and Meng SS:
14-3-3ζ silencing retards tongue squamous cell carcinoma
progression by inhibiting cell survival and migration. Cancer Gene
Ther. 23:206–213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu S, Wu Y, Yang T, Feng C and Jiang H:
Coexistence of YWHAZ amplification predicts better prognosis in
muscle-invasive bladder cancer with CDKN2A or TP53 loss.
Oncotarget. 7:34752–34758. 2016.PubMed/NCBI
|
|
11
|
Feng C, Xiong Z, Jiang H, Ding Q, Fang Z
and Hui W: Genetic alteration in notch pathway is associated with
better prognosis in renal cell carcinoma. Biofactors. 42:41–48.
2016.PubMed/NCBI
|
|
12
|
Feng C, Ding G, Jiang H, Ding Q and Wen H:
Loss of MLH1 confers resistance to PI3Kβ inhibitors in renal clear
cell carcinoma with SETD2 mutation. Tumour Biol. 36:3457–3464.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feng C, Sun Y, Ding G, Wu Z, Jiang H, Wang
L, Ding Q and Wen H: PI3Kβ inhibitor TGX221 selectively inhibits
renal cell carcinoma cells with both VHL and SETD2 mutations and
links multiple pathways. Sci Rep. 5:94652015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Subramanian A, Kuehn H, Gould J, Tamayo P
and Mesirov JP: GSEA-P: A desktop application for Gene Set
Enrichment Analysis. Bioinformatics. 23:3251–3253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Li Y, Lin C, Ding J, Liao G and
Tang B: Aberrant upregulation of 14-3-3σ and EZH2 expression serves
as an inferior prognostic biomarker for hepatocellular carcinoma.
PLoS One. 9:e1072512014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun N, Wu Y, Huang B, Liu Q, Dong Y, Ding
J and Liu Y: Decreased expression of 14-3-3σ, an early event of
malignant transformation of respiratory epithelium, also
facilitates progression of squamous cell lung cancer. Thorac
Cancer. 6:715–721. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mackintosh C: Dynamic interactions between
14-3-3 proteins and phosphoproteins regulate diverse cellular
processes. Biochem J. 381:329–342. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sunayama J, Tsuruta F, Masuyama N and
Gotoh Y: JNK antagonizes Akt-mediated survival signals by
phosphorylating 14-3-3. J Cell Biol. 170:295–304. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoshida K, Yamaguchi T, Natsume T, Kufe D
and Miki Y: JNK phosphorylation of 14-3-3 proteins regulates
nuclear targeting of c-Abl in the apoptotic response to DNA damage.
Nat Cell Biol. 7:278–285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen MS, Ryan CE and Piwnica-Worms H: Chk1
kinase negatively regulates mitotic function of Cdc25A phosphatase
through 14-3-3 binding. Mol Cell Biol. 23:7488–7497. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lavecchia A, Di Giovanni C and Novellino
E: Inhibitors of Cdc25 phosphatases as anticancer agents: A patent
review. Expert Opin Ther Pat. 20:405–425. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sur S and Agrawal DK: Phosphatases and
kinases regulating CDC25 activity in the cell cycle: Clinical
implications of CDC25 overexpression and potential treatment
strategies. Mol Cell Biochem. 416:33–46. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Z, Zhang G and Kong C: High
expression of Cdc25B and low expression of 14-3-3σ is associated
with the development and poor prognosis in urothelial carcinoma of
bladder. Tumour Biol. 35:2503–2512. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mils V, Baldin V, Goubin F, Pinta I, Papin
C, Waye M, Eychene A and Ducommun B: Specific interaction between
14-3-3 isoforms and the human CDC25B phosphatase. Oncogene.
19:1257–1265. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tong S, Xia T, Fan K, Jiang K, Zhai W, Li
JS, Wang SH and Wang JJ: 14-3-3ζ promotes lung cancer cell invasion
by increasing the Snail protein expression through atypical protein
kinase C (aPKC)/NF-κB signaling. Exp Cell Res. 348:1–9. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
MacKay RK, Colson NJ, Dodd PR and Lewohl
JM: Differential expression of 14-3-3 isoforms in human alcoholic
brain. Alcohol Clin Exp Res. 35:1041–1049. 2011. View Article : Google Scholar : PubMed/NCBI
|
